1983
DOI: 10.1016/0304-4165(83)90092-2
|View full text |Cite
|
Sign up to set email alerts
|

Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
87
0
3

Year Published

1996
1996
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 132 publications
(94 citation statements)
references
References 29 publications
3
87
0
3
Order By: Relevance
“…These include (i) prevention of the expression of cyclo-oxygenase (COX II) caused by endotoxin (Masferrer et al, 1992) or LTA , (ii) prevention of the generation of platelet-activating factor (PAF; Parente & Flower, 1985), (iii) attenuation of the formation of TNFa (Beutler et al, 1986;Flower, 1988; this study), (iv) prevention of the expression of adhesion molecules as well as activation of neutrophils (Cronstein et al, 1992). In addition to inhibiting iNOS activity, aminoguanidine also inhibits polyamine catabolism (Seiler et al, 1985), catalase activity (Ou & Wolff, 1993), histamine metabolism (Bieganski et al, 1983) as well as the formation of glycosylation end products (Brownlee et al, 1988;Edelstein & Brownlee, 1992). Our finding that pretreatment of rats with aminoguanidine prevents the LTA + PepG induced expression of iNOS protein and activity (lung), without affecting TNFa production, highlights the fact that aminoguanidine exerts non-specific effects which are unrelated to inhibition of iNOS activity.…”
Section: Experimental Protocolmentioning
confidence: 73%
“…These include (i) prevention of the expression of cyclo-oxygenase (COX II) caused by endotoxin (Masferrer et al, 1992) or LTA , (ii) prevention of the generation of platelet-activating factor (PAF; Parente & Flower, 1985), (iii) attenuation of the formation of TNFa (Beutler et al, 1986;Flower, 1988; this study), (iv) prevention of the expression of adhesion molecules as well as activation of neutrophils (Cronstein et al, 1992). In addition to inhibiting iNOS activity, aminoguanidine also inhibits polyamine catabolism (Seiler et al, 1985), catalase activity (Ou & Wolff, 1993), histamine metabolism (Bieganski et al, 1983) as well as the formation of glycosylation end products (Brownlee et al, 1988;Edelstein & Brownlee, 1992). Our finding that pretreatment of rats with aminoguanidine prevents the LTA + PepG induced expression of iNOS protein and activity (lung), without affecting TNFa production, highlights the fact that aminoguanidine exerts non-specific effects which are unrelated to inhibition of iNOS activity.…”
Section: Experimental Protocolmentioning
confidence: 73%
“…Wäh rend der über Nacht bei Raum tem pe ra tur (18 -26 °C) statt fin den den In ku ba ti on wur de das His ta min durch die in der Pro be vor han de ne DAO ab ge baut. Im nächs ten [20]. Das Serum al ler Pa tien ten wur de 2-mal ana ly siert.…”
Section: Methodeunclassified
“…Es wur den schon vie le Stu dien zum Thema His ta mi nin to le ranz und Kor re la ti on zu einer re du zier ten DAO-Ak ti vi tät ver öf fent licht [15,18,20,21]. Die Di ag no se HIT wird norma ler wei se ge stellt, wenn ty pi sche HITSymptome auf tre ten, die sich nach ei ner hista min frei en Diät bes sern [22].…”
Section: Diskussionunclassified
“…Diamine oxidase D i a m i n e ox i d a s e ( DAO ) , a c y t o p l a s m i c e n z y m e found in almost all organs is present in a particularly high concentration in the epithelial cells of the small intestine [44][45][46] . Following injury to intestinal epithelial cells DAO is released into the intestinal lumen and intercellular space where it is taken up by lymphatics and blood vessels [45] .…”
Section: Mucosal Transport and Barrier Functionmentioning
confidence: 99%